MedPath

Cefotaxime

Cefotaxime for Injection, USP

Approved
Approval ID

ef1a6dc6-bc3d-4f09-8f92-7ff328f56561

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 15, 2018

Manufacturers
FDA

West-Ward Pharmaceuticals Corp

DUNS: 001230762

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefotaxime

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0143-9935
Application NumberANDA065071
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefotaxime
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateSeptember 17, 2018
FDA Product Classification

INGREDIENTS (1)

CEFOTAXIME SODIUMActive
Quantity: 10 g in 1 1
Code: 258J72S7TZ
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefotaxime - FDA Drug Approval Details